Published in J Asthma on August 08, 2011
Failure in asthma control: reasons and consequences. Scientifica (Cairo) (2013) 0.98
Association of obstructive sleep apnea risk or diagnosis with daytime asthma in adults. J Asthma (2012) 0.92
Role of obesity in asthma control, the obesity-asthma phenotype. J Allergy (Cairo) (2013) 0.84
Obesity in asthma: approaches to treatment. Curr Allergy Asthma Rep (2013) 0.84
Body mass index and comorbidities in adult severe asthmatics. Biomed Res Int (2014) 0.83
Abdominal and general adiposity and level of asthma control in adults with uncontrolled asthma. Ann Am Thorac Soc (2014) 0.80
A pilot randomized controlled trial of pioglitazone for the treatment of poorly controlled asthma in obesity. Respir Res (2015) 0.80
Obesity and symptoms of depression contribute independently to the poor asthma control of obesity. Respir Med (2014) 0.80
Immunological characteristics and management considerations in obese patients with asthma. Expert Rev Clin Immunol (2015) 0.76
Central obesity and other factors associated with uncontrolled asthma in women. Allergy Asthma Clin Immunol (2015) 0.75
The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med (1993) 35.93
Development and validation of a questionnaire to measure asthma control. Eur Respir J (1999) 9.35
Prospective study of body mass index, weight change, and risk of adult-onset asthma in women. Arch Intern Med (1999) 6.21
Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med (2002) 5.98
Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med (2009) 5.90
Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med (2007) 3.95
Influence of body mass index on the response to asthma controller agents. Eur Respir J (2006) 2.41
Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. Chest (1998) 2.28
Body mass index and asthma severity in the National Asthma Survey. Thorax (2008) 2.26
Gastroesophageal reflux in asthmatics: A double-blind, placebo-controlled crossover study with omeprazole. Chest (1999) 1.99
The relationship between obesity and asthma severity and control in adults. J Allergy Clin Immunol (2008) 1.96
Obesity and asthma. Pharmacol Ther (2005) 1.83
Does higher body mass index contribute to worse asthma control in an urban population? J Allergy Clin Immunol (2009) 1.79
Predictors of habitual snoring and obstructive sleep apnea risk in patients with asthma. Chest (2008) 1.73
Body mass index and phenotype in subjects with mild-to-moderate persistent asthma. J Allergy Clin Immunol (2009) 1.43
Effect of nasal continuous positive airway pressure in uncontrolled nocturnal asthmatic patients with obstructive sleep apnea syndrome. Respir Med (2004) 1.41
Relation of bronchial responsiveness to body mass index in the ECRHS. European Community Respiratory Health Survey. Thorax (2002) 1.34
Effect of obesity on clinical presentation and response to treatment in asthma. J Asthma (2006) 1.26
Intraesophageal perfusion of acid increases the bronchomotor response to methacholine and to isocapnic hyperventilation in asthmatic subjects. Am Rev Respir Dis (1986) 1.26
Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma. J Allergy Clin Immunol (2009) 1.18
Obstructive sleep apnea syndrome and asthma: what are the links? J Clin Sleep Med (2009) 1.17
Association of obstructive sleep apnea risk with asthma control in adults. Chest (2010) 1.09
Sleep quality in asthma: results of a large prospective clinical trial. J Asthma (2008) 1.08
Effects of asymptomatic proximal and distal gastroesophageal reflux on asthma severity. Am J Respir Crit Care Med (2009) 1.01
Obstructive sleep apnea syndrome and asthma: the role of continuous positive airway pressure treatment. Ann Allergy Asthma Immunol (2008) 0.91
Pulmonary responses to tracheal or esophageal acidification in guinea pigs with airway inflammation. J Appl Physiol (1985) (2002) 0.84
Do obese adults have a higher risk of asthma attack when exposed to indoor mold? A study based on the 2005 Behavioral Risk Factor Surveillance System. Public Health Rep (2009) 0.83
Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48
Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med (2009) 5.90
An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med (2011) 5.53
Defining a link with asthma in mice congenitally deficient in eosinophils. Science (2004) 5.20
Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med (2007) 4.40
TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol (2008) 3.42
Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. JAMA (2012) 3.40
The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol (2006) 3.25
Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer. J Immunother (2013) 2.80
Exercise for fun and profit: joint statement on exercise by the American Thoracic Society and the American College of Chest Physicians. Chest (2004) 2.76
Knowledge and use of office spirometry for the detection of chronic obstructive pulmonary disease by primary care physicians. Respir Care (2005) 2.72
An official American Thoracic Society clinical practice guideline: exercise-induced bronchoconstriction. Am J Respir Crit Care Med (2013) 2.69
A reevaluation of the validity of unrestrained plethysmography in mice. J Appl Physiol (1985) (2002) 2.63
Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. Am J Respir Crit Care Med (2005) 2.56
Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation. J Allergy Clin Immunol (2011) 2.53
The allergic mouse model of asthma: normal smooth muscle in an abnormal lung? J Appl Physiol (1985) (2003) 2.44
Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol (2003) 2.44
Unrestrained plethysmography is an unreliable measure of airway responsiveness in BALB/c and C57BL/6 mice. J Appl Physiol (1985) (2004) 2.43
Exercise-induced bronchoconstriction in athletes. Chest (2005) 2.39
Six-month natural history of oral versus cervical human papillomavirus infection. Int J Cancer (2007) 2.37
Barrett's oesophagus. Lancet (2009) 2.21
Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope (2006) 2.17
Airway hyperresponsiveness in allergically inflamed mice: the role of airway closure. Am J Respir Crit Care Med (2007) 2.16
Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population. Nat Genet (2011) 2.10
The effect of point-of-care ultrasonography on imaging studies in the medical ICU: a comparative study. Chest (2014) 2.04
Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial. Ophthalmology (2011) 2.00
A prominent role for airway epithelial NF-kappa B activation in lipopolysaccharide-induced airway inflammation. J Immunol (2003) 1.99
Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancer. Cancer Res (2008) 1.99
ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol (2007) 1.98
Measuring lung function in mice: the phenotyping uncertainty principle. J Appl Physiol (1985) (2003) 1.93
Airway and tissue mechanics in a murine model of asthma: alveolar capsule vs. forced oscillations. J Appl Physiol (1985) (2002) 1.92
Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response. Pharmacogenet Genomics (2009) 1.90
Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults. Am J Epidemiol (2014) 1.88
The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. Am J Ophthalmol (2010) 1.83
Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers. J Allergy Clin Immunol (2009) 1.81
Role of IL-6 in asthma and other inflammatory pulmonary diseases. Int J Biol Sci (2012) 1.79
Surgical fundoplication in laryngopharyngeal reflux unresponsive to aggressive acid suppression: a controlled study. Clin Gastroenterol Hepatol (2006) 1.79
A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction. Clin Cancer Res (2011) 1.78
NF-kappa B activation in airways modulates allergic inflammation but not hyperresponsiveness. J Immunol (2004) 1.73
Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness. J Clin Invest (2004) 1.70
Asthma in the elderly: Current understanding and future research needs--a report of a National Institute on Aging (NIA) workshop. J Allergy Clin Immunol (2011) 1.69
Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure. Am J Gastroenterol (2003) 1.68
Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough. Gastroenterology (2002) 1.67
Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol (2002) 1.66
Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association. Clin Gastroenterol Hepatol (2003) 1.66
Rapid activation of nuclear factor-kappaB in airway epithelium in a murine model of allergic airway inflammation. Am J Pathol (2002) 1.66
FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. Chest (2006) 1.65
Transforming growth factor-beta1 suppresses airway hyperresponsiveness in allergic airway disease. Am J Respir Crit Care Med (2007) 1.63
Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-beta1. J Cell Sci (2008) 1.60
Adjuvant chemoradiation therapy for adenocarcinoma of the distal pancreas. Ann Surg Oncol (2010) 1.60
p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression. Am J Gastroenterol (2002) 1.58
Methacholine challenge test: diagnostic characteristics in asthmatic patients receiving controller medications. J Allergy Clin Immunol (2012) 1.57
The nonallergic asthma of obesity. A matter of distal lung compliance. Am J Respir Crit Care Med (2014) 1.57
Pneumatic dilation for the treatment of achalasia in untreated patients and patients with failed Heller myotomy. J Clin Gastroenterol (2004) 1.57
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma. Cancer (2014) 1.55
Airway smooth muscle as a target for asthma therapy. N Engl J Med (2007) 1.54
The relationship between gastroesophageal reflux and asthma: an update. Ther Adv Respir Dis (2010) 1.54
Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema. Ophthalmology (2013) 1.51
A physiologic clinical study of achalasia: should Dor fundoplication be added to Heller myotomy? J Thorac Cardiovasc Surg (2005) 1.42
Trends and outcomes of hospitalizations for peptic ulcer disease in the United States, 1993 to 2006. Ann Surg (2010) 1.40
Nuclear factor-kappaB activation in airway epithelium induces inflammation and hyperresponsiveness. Am J Respir Crit Care Med (2008) 1.40
Intrinsic and antigen-induced airway hyperresponsiveness are the result of diverse physiological mechanisms. J Appl Physiol (1985) (2006) 1.39
Asthma, the sex difference. Curr Opin Pulm Med (2011) 1.39
Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope (2005) 1.38
Natural history of anal vs oral HPV infection in HIV-infected men and women. J Infect Dis (2013) 1.37
ARG1 is a novel bronchodilator response gene: screening and replication in four asthma cohorts. Am J Respir Crit Care Med (2008) 1.34
Nuclear factor kappaB, airway epithelium, and asthma: avenues for redox control. Proc Am Thorac Soc (2009) 1.31
Animal models of asthma. Am J Physiol Lung Cell Mol Physiol (2009) 1.31
Time dependence of recruitment and derecruitment in the lung: a theoretical model. J Appl Physiol (1985) (2002) 1.31
The pathogenesis of pseudoachalasia: a clinicopathologic study of 13 cases of a rare entity. Am J Surg Pathol (2002) 1.29
Elevation of IL-6 in the allergic asthmatic airway is independent of inflammation but associates with loss of central airway function. Respir Res (2010) 1.29
Obesity and asthma: an inflammatory disease of adipose tissue not the airway. Am J Respir Crit Care Med (2012) 1.28
c-Jun N-terminal kinase 1 is required for the development of pulmonary fibrosis. Am J Respir Cell Mol Biol (2008) 1.26
Effect of obesity on clinical presentation and response to treatment in asthma. J Asthma (2006) 1.26
The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers. J Voice (2002) 1.25
Hospital-acquired gastrointestinal bleeding outside the critical care unit: risk factors, role of acid suppression, and endoscopy findings. J Hosp Med (2006) 1.25
Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation. Proc Natl Acad Sci U S A (2008) 1.22
Trends in gastroesophageal reflux disease as measured by the National Ambulatory Medical Care Survey. Dig Dis Sci (2009) 1.21
The association between gastroesophageal reflux disease and obesity. Am J Gastroenterol (2008) 1.18
Communication skills training curriculum for pulmonary and critical care fellows. Ann Am Thorac Soc (2015) 1.18
Allergic rhinitis and sinusitis in asthma: differential effects on symptoms and pulmonary function. Chest (2006) 1.17
The diagnosis of gastroesophageal reflux disease. Am J Med (2010) 1.17
Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the Esophageal Diagnostic Advisory Panel. J Am Coll Surg (2013) 1.16
Predicting episodes of poor asthma control in treated patients with asthma. J Allergy Clin Immunol (2006) 1.16
Prevalence of exercise-induced bronchospasm in a cohort of varsity college athletes. Med Sci Sports Exerc (2007) 1.15
Inhibition of arginase activity enhances inflammation in mice with allergic airway disease, in association with increases in protein S-nitrosylation and tyrosine nitration. J Immunol (2008) 1.13
Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians. Am J Gastroenterol (2006) 1.12
Computational assessment of airway wall stiffness in vivo in allergically inflamed mouse models of asthma. J Appl Physiol (1985) (2008) 1.11
The synergistic interactions of allergic lung inflammation and intratracheal cationic protein. Am J Respir Crit Care Med (2007) 1.10
Genome-wide association analysis in asthma subjects identifies SPATS2L as a novel bronchodilator response gene. PLoS Genet (2012) 1.09
Complexities of managing achalasia at a tertiary referral center: use of pneumatic dilatation, Heller myotomy, and botulinum toxin injection. Am J Gastroenterol (2004) 1.08
Inhaled salmeterol and/or fluticasone alters structure/function in a murine model of allergic airways disease. Respir Res (2010) 1.08